These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31632493)

  • 21. Development and validation of a nomogram prediction model based on albumin-to-alkaline phosphatase ratio for predicting the prognosis of gallbladder carcinoma.
    Fan Z; Liu B; Shang P
    Pathol Oncol Res; 2022; 28():1610818. PubMed ID: 36685104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer.
    Li YT; Zhou XS; Han XM; Tian J; Qin Y; Zhang T; Liu JL
    World J Gastrointest Oncol; 2022 May; 14(5):1002-1013. PubMed ID: 35646278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
    Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
    Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Liver Function for Evaluation of Long-Term Outcomes of Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis of 620 Patients.
    Li H; Li J; Wang J; Liu H; Cai B; Wang G; Wu H
    Front Oncol; 2020; 10():525. PubMed ID: 32411593
    [No Abstract]   [Full Text] [Related]  

  • 25. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients.
    Long ZQ; Hua X; Zhang WW; Lv SW; Deng JP; Guo L; He ZY; Lin HX
    Cancer Manag Res; 2019; 11():4809-4814. PubMed ID: 31213902
    [No Abstract]   [Full Text] [Related]  

  • 27. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator in patients undergoing peritoneal dialysis: a propensity score matching analysis.
    Xia W; Hua X; Sun D; Xie X; Hu H
    Front Med (Lausanne); 2024; 11():1302603. PubMed ID: 38698782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
    Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
    Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of pretreatment albumin-to-alkaline phosphatase ratio for overall survival for patients with advanced non-small cell lung cancer.
    Zhou S; Jiang W; Wang H; Wei N; Yu Q
    Cancer Med; 2020 Sep; 9(17):6268-6280. PubMed ID: 32691996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma.
    Yoshino M; Ishihara H; Ishiyama Y; Tachibana H; Toki D; Yamashita K; Kobayashi H; Fukuda H; Yoshida K; Takagi T; Iizuka J; Ishida H; Kondo T; Tanabe K
    In Vivo; 2021; 35(5):2855-2862. PubMed ID: 34410978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Significance of Preoperative Albumin to Alkaline Phosphatase Ratio in Patients with Glioblastoma.
    Li J; Zuo M; Zhou X; Xiang Y; Zhang S; Feng W; Liu Y
    J Cancer; 2021; 12(19):5950-5959. PubMed ID: 34476009
    [No Abstract]   [Full Text] [Related]  

  • 32. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.
    Nie M; Sun P; Chen C; Bi X; Wang Y; Yang H; Liu P; Li Z; Xia Y; Jiang W
    J Cancer; 2017; 8(5):809-815. PubMed ID: 28382143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery.
    Xiong JP; Long JY; Xu WY; Bian J; Huang HC; Bai Y; Xu YY; Zhao HT; Lu X
    World J Gastrointest Oncol; 2019 Jan; 11(1):39-47. PubMed ID: 30984349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible?
    An L; Yin WT; Sun DW
    BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment Albumin-to-Alkaline Phosphatase Ratio Is a Prognostic Marker in Lung Cancer Patients: A Registry-Based Study of 7077 Lung Cancer Patients.
    Sandfeld-Paulsen B; Aggerholm-Pedersen N; Winther-Larsen A
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Albumin-to-alkaline phosphatase ratio: A novel prognostic index for patients with driver mutation-negative advanced non-small cell lung cancer.
    Liu X; Li Y; Zhao Q; Jiang H; Ni J; Cai H
    Clin Respir J; 2021 May; 15(5):540-549. PubMed ID: 33565707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
    Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
    J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
    [No Abstract]   [Full Text] [Related]  

  • 39. Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer.
    Qu F; Li Z; Lai S; Zhong X; Fu X; Huang X; Li Q; Liu S; Li H
    Front Oncol; 2021; 11():681905. PubMed ID: 34692474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment albumin-to-alkaline phosphatase ratio as a prognostic indicator in solid cancers: A meta-analysis with trial sequential analysis.
    Tian G; Li G; Guan L; Yang Y; Li N
    Int J Surg; 2020 Sep; 81():66-73. PubMed ID: 32745716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.